NATIONAL INSTITUTES OF HEALTH/NIDCR
BUILDING 45, Room 4AS25L
MSC 6401
BETHESDA MD 20892-6401
Phone: (301) 435-7908
E-mail: jatkinso@mail.nih.gov
Research Interests
Clinical studies in salivary gland diseases; therapeutic trials
Education
D.D.S., University of Missouri – Kansas City, 1981
Certificate, Clinical Research / Oral Medicine, National Institute of Dental and Craniofacial Research, 1988
Recent Publications
Brennan MT, Sankar V, Leakan RA, Kleiner D, Atkinson JC, Wilkinson E, Baum BJ, Pillemer SR. Risk factors for a positive minor salivary gland biopsy in Sjögren’s syndrome. Arthritis Rheum 2002; 47:189-95.
Brennan MT, Sankar V, Baccaglini L, Pillemer SR, Kingman A, Nunez O, Young NS, Atkinson JC. Oral manifestations in patients with aplastic anemia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001; 92:503-8.
Atkinson JC, Zeller GG, Shah C. Electronic patient records for dental school clinics: more than paperless records. J Dent Educ 2002; 66:634-42.
Sankar V, Baccaglini L, Sawdey M, Wheeler CJ, Pillemer SR, Baum BJ, Atkinson JC. Salivary Gland Delivery of pDNA-Cationic Lipoplexes Elicits Systemic Immune Responses. Oral Diseases 2002; 8:275-81.
Akintoye SO, Otis LL, Atkinson JC, Brahim J, Kushner H, Robey PG, Collins MT. Analyses of variable panoramic radiographic characteristics of maxillo-mandibular fibrous dysplasia in McCune-Albright syndrome. Oral Dis. 2004 10: 36-43.
Mulshine JL, Atkinson JC, Greer RO, Papadimitrakopoulou VA, Van Waes C, Rudy S, Martin JW, Steinberg SM, Liewehr DJ, Avis I, Linnoila RI, Hewitt S, Lippman SM, Frye R, Cavanaugh PF Jr. Randomized, double-blind, placebo-controlled phase IIb trial of the cyclooxygenase inhibitor ketorolac as an oral rinse in oropharyngeal leukoplakia. Clin Cancer Res. 2004; 10:1565-73.
Atkinson JC, Grisius M, Massey W. Salivary hypofunction and xerostomia: diagnosis and treatment. Dent Clin North Am. 2005; 49:309-26.
Shulman HM, Kleiner D, Lee SJ, Morton T, Pavletic SZ, Farmer E, Moresi JM, Greenson J, Janin A, Martin PJ, McDonald G, Flowers MED, Turner M, Atkinson J, Lefkowitch J, Washington MK, Prieto VG, Kim S, Argenyi A, Diwan AH, Rashid A, Hiatt K, Hymes S, Vogelsang GB. Histopathologic diagnosis of chronic graft versus host disease. NIH consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. Pathology working group report. Biol Blood Marrow Transplant 2006 ;12:31-47.
Ryu, OK, Atkinson, JC, Hoehn, GT, Illei, GG, Hart TC. Identification of parotid salivary biomarkers in Sjögren’s Syndrome by surface enhanced laser desorption/ionization-time of flight-mass spectrometry, 2 dimensional-difference in gel electrophoresis. Rheumatology 2006; 45:1077-86.
Imanguli MM, Pavletic SZ, Guadagnini JP, Brahim JS, Atkinson JC. Chronic graft versus host disease of oral mucosa: review of available therapies. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006; 101:175-83.
Baum BJ, Zheng C, Cotrim AP, Goldsmith CM, Atkinson JC, Brahim JS, Chiorini JA, Voutetakis A, Leakan RA, Van Waes C, Mitchell JB, Delporte C, Wang S, Kaminsky SM, Illei GG. Transfer of the AQP1 cDNA for the correction of radiation-induced salivary hypofunction. Biochim Biophys Acta. 2006; 1758:1071-7.
Imanguli MM, Atkinson JC, Harvey KE, Hoehn GT, Ryu OK, Wu T, Kingman A, Barrett AJ, Bishop MR, Childs RW, Fowler DH, Pavlectic SZ, Hart TC. Changes in salivary proteome following allogeneic hematopoietic stem cell transplantation. Exp Hematol, Exp Hematol. 2007 Feb;35(2):184-92.
Baccaglini L, Atkinson JC, Patton LL, Glick M, Ficarra G, Peterson DE. Management of oral lesions in HIV-positive patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Mar;103 Suppl:S50.e1-S50.e23.